<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03205098</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-340</org_study_id>
    <secondary_id>2015-A00470-49</secondary_id>
    <nct_id>NCT03205098</nct_id>
  </id_info>
  <brief_title>Evaluation of Biological Markers of Mesenteric Ischemia During an Ultra-trail</brief_title>
  <acronym>ISKETRAIL</acronym>
  <official_title>Evaluation of Biological Markers of Mesenteric Ischemia During an Ultra-trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the evolution of biological markers of mesenteric ischemia during ultratrail.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During physical exercise, increased sympathetic nervous system activity redistributes blood
      flow from splanchnic organs to working muscles. With prolonged duration and / or intensity,
      the splanchnic blood flow can be reduced by 80% or more. A severely reduced of splanchnic
      blood flow can frequently cause gastrointestinal ischemia. This ischemia associated with
      reduced vagal activity probably results in changes in motility and absorption.

      High symptoms are reported in 40% of runners with reflux and heartburn in 15-20% of runners.
      The low symptoms have an incidence of about 70% in the long runs type ultra-trail.

      Biological markers such as I-FABP have been shown to be useful in the diagnosis of mesenteric
      ischemia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 19, 2015</start_date>
  <completion_date type="Actual">September 30, 2016</completion_date>
  <primary_completion_date type="Actual">June 30, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assess biological markers of mesenteric ischemia (IFABP)</measure>
    <time_frame>at day 1</time_frame>
    <description>during ultratrail.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship between digestive symptoms and biological markers (IFABP).</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Ultra-trail Participation</condition>
  <arm_group>
    <arm_group_label>Runners</arm_group_label>
    <description>To assess the evolution of biological markers of mesenteric ischemia during ultratrail.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood analysis</intervention_name>
    <description>Blood test of biological markers of mesenteric ischemia</description>
    <arm_group_label>Runners</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        participants or populations are selected based on predefined criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Voluntary Subject

          -  Age &gt; 18 years

          -  Written consent

          -  Subject affiliated to Social Security

          -  Medical certificate (mandatory to take part in the ultra-trail)

        Exclusion Criteria:

          -  Refusal to participate

          -  Subject with legal protection (guardianship, trusteeship)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SÃ©bastien PERBET</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Auvergne</state>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2017</study_first_submitted>
  <study_first_submitted_qc>June 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>June 29, 2017</last_update_submitted>
  <last_update_submitted_qc>June 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biological markers</keyword>
  <keyword>mesenteric ischemia</keyword>
  <keyword>ultratrail</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Mesenteric Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

